H.U. Group Holdings
H.U. Group Holdings Inc, formerly Miraca Holdings, is a Japanese clinical diagnostics and healthcare services company operating across clinical laboratory testing and IVD manufacturing. The company operates central clinical testing laboratories, manufactures diagnostic reagents and equipment under Fujirebio, and provides healthcare logistics services. Principal revenues derive from fee-for-service clinical laboratory testing charges alongside wholesale sales of in vitro diagnostic instruments and reagent kits. Core end markets serve public and private hospitals, physician clinics, medical diagnostic centers, and academic research institutions across Japan, Europe, and the Americas. H.U. Group Holdings holds the market-leading position in Japan for outsourced clinical laboratory testing services. The corporation is headquartered in Tokyo, Japan, and its shares trade on the Tokyo Stock Exchange.
9 of the funds FundTelligence covers report a position in H.U. Group Holdings.
- Legal name
- H.U. Group Holdings Inc
- Sector
- Health Care
- Country
- Japan
- Funds holding it
- 9
Funds holding H.U. Group Holdings
- Schroder ISF Global Dividend Maximiser — Schroders · 1.09 % (full portfolio disclosed, June 2026)
- Schroder ISF Global Equity Yield — Schroders · 1.06 % (full portfolio disclosed, June 2026)
- Schroder ISF Global Sustainable Value — Schroders · 1.04 % (full portfolio disclosed, June 2026)
- Schroder ISF Global Recovery — Schroders · 0.96 % (full portfolio disclosed, June 2026)
- Mercer Global Small Cap Equity Fund — Mercer · 0.23 % (full portfolio disclosed, December 2025)
- Storebrand Global Multifactor — Storebrand · 0.22 % (full portfolio disclosed, October 2026)
- DNB Global Enhanced Small Cap — DNB · 0.02 % (full portfolio disclosed, September 2026)
- Handelsbanken Global SMB Index Criteria — Handelsbanken · 0.01 % (full portfolio disclosed, October 2026)
Showing the 8 largest of 9 funds holding it.